[🩹] Why’s Wall Street pouring money into this tiny biotech?

The "Blood-Brain Barrier" or BBB, is one of modern medicine's last frontiers.

View in Browser MARKET SOLUTION Saturday, 18 • April 2024 The "Blood-Brain Barrier" or BBB, is one of modern medicine's last frontiers. Usually, it prevents medications from crossing into the brain, and it makes treating neurological disease difficult, if not impossible. But scientists at this little-known biotech are close to breaking through it. Their revolutionary technique helps transport drugs across the BBB, allowing for safer and more effective treatments than ever before. This biotech currently has four drugs in mid to late-stage clinical trials. And any one that gets approved could send their share price skyrocketing. Institutional investors are taking notice... They more than doubled their stock purchases of the company in the final quarter of 2023... Do they know something you don't? Get the full details here...before the opportunity is gone. "The Buck Stops Here," Dylan Jovine, CEO & Founder Behind the Markets Polaris Advertising welcomes your feedback and questions. But please note: The law prohibits us from giving personalized advice. To ensure our emails continue reaching your inbox, please add our email address to your address book. Any reproduction, copying, or redistribution of our content, in whole or in part, is prohibited without written permission from Polaris Advertising.   To contact Us, call toll free Domestic/International Mon–Fri, 9am–5pm ET, or email us    © 2024 Polaris Advertising. All rights reserved. 124 Broadkill Rd  4 Milton, DE 19968.   This editorial email containing advertisements was sent to its028@gmail.com because you subscribed to this service. To stop receiving these emails, click unsubscribe.